Literature DB >> 22666755

Combination hyperbaric oxygen and temozolomide therapy in C6 rat glioma model.

Yaşar Dagıstan1, Ismail Karaca, Erol Ruştu Bozkurt, Engin Ozar, Kaan Yagmurlu, Akin Toklu, Ayhan Bilir.   

Abstract

PURPOSE: Temozolomide (TMZ) has anti-tumor activity in patients with malignant glioma. Hyperbaric oxygen (HBO) may enhance the efficacy of certain therapies that are limited because of the hypoxic tumor microenvironment. We examined the combined effects of TMZ-HBO in a rat glioma model.
METHODS: After stereotactic injection of C6/LacZ rat glioma cells into the Wistar rats brain, the rats were randomly assigned to three treatment groups [group 1, control treatment; group 2, TMZ alone; group 3, a combination of TMZ and HBO]. Rats were sacrificed 18 days after treatment, and number of intra-/peri-tumoral vessels, microendothelial proliferations, immunohistochemistry and necrotic area were evaluated.
RESULTS: Tumoral tissue was stained only sparsely with GFAP. Temozolomide treatment was significantly decreased in tumor tissue intratumoral vessel number / total tumor area level. The level of Ki67 was significantly decreased in the tumor tissue of the group 3. Additionally, the total necrotic area / total tumor volume (%) was decreased significantly in tumor tissue of the group 3 rats compared to group 1 and 2.
CONCLUSION: The combination of hyperbaric oxygen with temozolomide produced an important reduction in glioma growth and effective approach to the treatment of glioblastoma.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22666755     DOI: 10.1590/s0102-86502012000600005

Source DB:  PubMed          Journal:  Acta Cir Bras        ISSN: 0102-8650            Impact factor:   1.388


  10 in total

Review 1.  C6 cell line: the gold standard in glioma research.

Authors:  D Giakoumettis; A Kritis; N Foroglou
Journal:  Hippokratia       Date:  2018 Jul-Sep       Impact factor: 0.471

Review 2.  Hyperbaric oxygen as an adjunctive therapy in treatment of malignancies, including brain tumours.

Authors:  Katarzyna Stępień; Robert P Ostrowski; Ewa Matyja
Journal:  Med Oncol       Date:  2016-08-02       Impact factor: 3.064

3.  HIF1α regulates glioma chemosensitivity through the transformation between differentiation and dedifferentiation in various oxygen levels.

Authors:  Pan Wang; Wenwu Wan; Shuanglong Xiong; Junwei Wang; Dewei Zou; Chuan Lan; Shuangjiang Yu; Bin Liao; Hua Feng; Nan Wu
Journal:  Sci Rep       Date:  2017-08-11       Impact factor: 4.379

4.  Hyperbaric oxygen inhibits production of CD3+ T cells in the thymus and facilitates malignant glioma cell growth.

Authors:  Yong-Gang Wang; Jiang Long; Dong-Chuan Shao; Hai Song
Journal:  J Int Med Res       Date:  2018-05-22       Impact factor: 1.671

5.  Hyperbaric oxygen increases glioma cell sensitivity to antitumor treatment with a novel isothiourea derivative in vitro.

Authors:  Katarzyna Zembrzuska; Robert P Ostrowski; Ewa Matyja
Journal:  Oncol Rep       Date:  2019-03-14       Impact factor: 3.906

6.  Hyperbaric oxygen suppresses stemness-associated properties and Nanog and oncostatin M expression, but upregulates β-catenin in orthotopic glioma models.

Authors:  Kun Song; Junrui Chen; Jianbo Ding; Hao Xu; Hongzhi Xu; Zhiyong Qin
Journal:  J Int Med Res       Date:  2019-12-09       Impact factor: 1.671

7.  Hyperbaric oxygen promotes not only glioblastoma proliferation but also chemosensitization by inhibiting HIF1α/HIF2α-Sox2.

Authors:  Pan Wang; Sheng Gong; Nan Wu; Bin Liao; Jinyu Pan; Junwei Wang; Dewei Zou; Shuanglong Xiong; Lu Zhao; Qian Yan; Yangming Deng
Journal:  Cell Death Discov       Date:  2021-05-13

8.  Intranasal delivery of camptothecin-loaded tat-modified nanomicells for treatment of intracranial brain tumors.

Authors:  Hiroyuki Taki; Takanori Kanazawa; Fuminari Akiyama; Yuuki Takashima; Hiroaki Okada
Journal:  Pharmaceuticals (Basel)       Date:  2012-10-15

9.  Effect of Hyperbaric Oxygen on the Growth of Intracranial Glioma in Rats.

Authors:  Jian-Bo Ding; Jun-Rui Chen; Hong-Zhi Xu; Zhi-Yong Qin
Journal:  Chin Med J (Engl)       Date:  2015-12-05       Impact factor: 2.628

Review 10.  Hyperbaric oxygen therapy as adjunctive strategy in treatment of glioblastoma multiforme.

Authors:  Lei Huang; Warren Boling; John H Zhang
Journal:  Med Gas Res       Date:  2018-04-18
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.